Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Karrie ZHOU, Miss
Assistant Lecturer
,
Chinese Medicine - Clinical Division
Email
karriezhou
hkbu.edu
hk
2024
2024
Research activity per year
Overview
Fingerprint
Network
Research Output
(1)
Similar Scholars
(9)
Fingerprint
Dive into the research topics where Karrie ZHOU is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Maintenance of Remission
100%
Placebo-controlled Trial
100%
Ulcerative Colitis
100%
Chinese Herbal Formula
100%
Chinese Herbal Medicine
50%
Remission
50%
Mayo Score
50%
Ulcerative Colitis Patient
50%
Simple Clinical Colitis Activity Index
25%
Clinical Relapse
25%
Inflammatory Bowel Disease Questionnaire
25%
Treatment Monitoring
25%
Placebo
25%
Scale Assessment
25%
Spleen Deficiency
25%
Recurrence Rate
25%
Dampness
25%
Drug Development
25%
Chinese Clinical Trial Registry
25%
Traditional Chinese Medicine Pattern
25%
Inflammatory Bowel Disease
25%
Randomized Placebo-controlled Trial
25%
Traditional Chinese Medicine
25%
Trial Registration
25%
Medicine Drugs
25%
Safety Assessment
25%
Traditional Chinese Medicine Syndrome
25%
Clinical Symptoms
25%
Patient's Will
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Ulcerative Colitis
100%
Remission
100%
Traditional Chinese Medicine
50%
Inflammatory Bowel Disease
33%
Obstruction
16%
Colitis
16%
Drug Development
16%
Recurrence Risk
16%
Clinical Trial
16%
Diseases
16%
Safety Assessment
16%
Controlled Clinical Trial
16%
Syndrome
16%
Medicine and Dentistry
Placebo
100%
Ulcerative Colitis
100%
Chinese Herbal Medicine
50%
Traditional Chinese Medicine
50%
Inflammatory Bowel Disease
33%
Obstruction
16%
Safety Assessment
16%
Controlled Clinical Trial
16%
Clinical Trial
16%
Diseases
16%
Recurrence Risk
16%
Colitis
16%
Patient Monitoring
16%
Primary Outcome
16%
Clinical Symptom
16%